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ABSTRACT
We have previously shown that Solanum glaucophyllum leaf extract
(SGE) increases VDR protein levels and promotes myoblast
differentiation. Here, we investigated whether p38 MAPK and AKT
are involved in SGE actions. Cell-cycle studies showed that SGE
prompted a peakof S-phase followed by an arrest in theG0/G1-phase
through p38 MAPK. Time course studies showed that p38 MAPK and
AKT phosphorylation were statistically increased by SGE (10 nM) or
synthetic 1α,25(OH)2D3 (1 nM) treatment. Furthermore, p38 MAPK
and AKT inhibitors, SB203580 and LY294002 respectively,
suppressed myoblasts fusion induced by SGE or synthetic
1α,25(OH)2D3. We have also studied differentiation genes by qRT-
PCR. myoD1 mRNA increased significantly by SGE (24–72 h) or
1α,25(OH)2D3 (24 h) treatment. mRNA expression of myogenin also
increased upon SGE or 1α,25(OH)2D3 treatment. Finally, MHC2b
mRNA expression, a late differentiation marker, was increased
significantly by both compounds at 72 h compared to control. Taken
together, these results suggest that SGE, as synthetic 1α,25(OH)2D3,
promotes myotube formation through p38 MAPK and AKT activation.
KEY WORDS: C2C12 cells, 1α,25(OH)2D3-glycosides, P38 MAPK,
AKT, MyoD1, Myogenin, MHC2b, Proliferation
INTRODUCTION
The biologically active form of vitamin D is 1α,25-
dihydroxyvitamin D3 [1α,25(OH)2D3], and it plays a key role in
calcium and phosphorus metabolism. More recently, important
pleiotropic effects have been described including: cell proliferation
inhibition, differentiation, anticarcinogenic effects, innate-
stimulation and adaptive immunity inhibition, inflammation
inhibition as well as several other endocrine and developmental
effects (Hewison, 2012; Plum and DeLuca, 2010; Bikle, 2011;
Hii and Ferrante, 2016). This form binds to the vitamin D receptor
(VDR) and regulates gene expression in a ligand-dependent manner
(Haussler et al., 2011; Hii and Ferrante, 2016). VDR is expressed in
skeletal muscle tissue at different stages, from myoblasts
(mononucleated cells) to myotubes (multinucleated cells).
Furthermore, the evidence of VDR presence has been reported in
rodent skeletal muscle cell lines (Simpson et al., 1985), in chicken
myoblasts monolayers (Boland et al., 1985) and in human skeletal
muscle cells (Costa et al., 1986).
The traditional activity of 1α,25(OH)2D3 to modulate gene
transcription is also complemented with its ability to regulate
intracellular, extranuclear pathways and cytoplasmic signaling
cascades. These cytoplasmic actions are generally regarded to be
rapid responses, taking place from within seconds to minutes.
Numerous studies detail the ability of 1α,25(OH)2D3 to affect
intracellular calcium levels as well as intracellular signaling
pathways involving kinases and phosphatases. The activation of
different signaling pathways is dependent on the cell type, thus
providing an avenue to explain the pleiotropic effects of vitamin D
(Wang and Sun, 2009; Audo et al., 2003; Sidelnikov et al., 2010; Hii
and Ferrante, 2016). Low vitamin D levels are associated with
different degrees of muscle dysfunction; consequently,
supplementation with vitamin D has generally shown beneficial
effects. Among dietary supplements the use of vitamin D3 has been
shown to improve bone health and muscle strength of broilers
(Papesova et al., 2008; Michalczuk et al., 2010; Garcia et al., 2013),
feedlot steers’ health (Montgomery et al., 2004) and meat
tenderness (Montgomery et al., 2002). However, 1α,25(OH)2D3 is
not available for animal nutrition because of high costs, but it
has been found that a few plants species have 1α,25(OH)2D3 and
other vitamin D3 metabolites (Boland et al., 2003). Solanum
glaucophyllum plants accumulate 1α,25(OH)2D3-glycosides, and
so their leaves become a natural source of the active form of vitamin
D. S. glaucophyllum leaf extract (SGE) is used in a cold water
solution for poultry breeding (Bachmann et al., 2013). One
advantage of SGE is that 1α,25(OH)2D3 can become available
quickly when entering the body as there is no need for the two
metabolic steps to become active (Rambeck et al., 1981). The active
component present in the plant extract has been shown to induce
calcium and phosphorus transport and thus it is recommended for
treatment of liver and/or kidney function impairment in older
animals and stress conditions (Bachmann et al., 2013; Edwards,
1989, 1993).
We have previously demonstrated that SGE increases VDR,
myogenin, and myosin heavy chain protein levels during the first
48 h of C2C12 muscle cell line differentiation (Gili et al., 2016).
Moreover, SGE improves the growth and differentiation of C2C12
cells at the onset of myogenesis, increasing cellular mass and
myotube fusion (Gili et al., 2016). In this work, we further studied
the effects of SGE on the signaling pathways involved in C2C12
muscle cell differentiation.Received 21 February 2018; Accepted 12 April 2018
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Skeletal muscle differentiation involves a complex process where a
broad number of signal pathways are coordinated. At the beginning
of the differentiation, satellite cells (muscle stem cells) commit to
myogenic precursor cells known as myoblasts. Successively, a
series of regulatory factors collaborate to differentiate the
myoblasts. To complete this process, mononuclear cells or
myocytes align and fuse to form multinuclear cells or myotubes
(Ge et al., 2013; Miyake et al., 2011). To further investigate the
mechanism of SGE on the differentiation of muscle cells, the
murine skeletal muscle cell line C2C12 was chosen. The regulation
of the cell cycle in C2C12 muscle cells treated with fetal bovine
serum (FBS) or synthetic 1α,25(OH)2D3 has been previously
reported (Irazoqui et al., 2014). In the present study, we first
examined the effect of SGE on C2C12 cell cycle progression. To
that end, cells were deprived of FBS for 16 h to synchronize the
cultures at a time in which 85% of the cells were growth-arrested in
the G0/G1-phase, as it was previously described (Irazoqui et al.,
2014). Then, arrested cells were stimulated with 10 nM of SGE for
different periods of time (6–48 h) and analyzed by flow cytometry.
Fig. 1A shows that the percentage of cells in the G0/G1-phase
increased after 6 h of SGE treatment whereas the G2/M phase
declined. Progression of the cell cycle from G1 to S-phase continued
and an S-phase peak was observed at 12 h. After completion of the
S-phase, an increase in the G0/G1-phase was observed at 24 h,
showing that one round of the cell cycle had been completed
and cells had begun preparing to start posterior differentiation.
This cell cycle pattern prompted by SGE was similar to the one
reported in C2C12 stimulated with synthetic 1α,25(OH)2D3
(Irazoqui et al., 2014).
Several downstream signaling pathways, including p38 MAPK,
Rho family small GTPases and AKT, are implicated in cell
myogenesis (Gonzalez et al., 2004; Takaesu et al., 2006; Bryan
et al., 2005). Transient or sustained MAPKs activation regulates
cellular fate mechanisms such as proliferation and differentiation.
The best characterized mammalian MAPKs are grouped into four
Fig. 1. Cell cycle progression of C2C12 skeletal muscle cells after SGE treatment: role of p38 MAPK. A. This panel shows a representative histogram
and DNA quantification from three independent experiments showing the percentage of cells in G0/G1-, S- and G2/M-phases (Y-axis label) ±s.d. Data were
analyzed by one way ANOVA, followed by t-test, **P<0.01. B. This panel presents a representative histogram and DNA quantification from four independent
experiments expressing the percentage of cells in G0/G1-, S- and G2/M-phases (Y-axis label) ±s.d. in combined bars graphs. Different letters mean
statistical differences with Tukey test.
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main modules, the ERK1/ERK2, JNK, p38 and ERK5 modules, but
more subgroups might exist (Kyriakis and Avruch, 2012). When
activated, MAPKs translocate into the nucleus and induce
transcription factor phosphorylation either directly or indirectly
through downstream kinases (Kyriakis and Avruch, 2012). p38
MAPK has been identified as an important signaling pathway to
promote skeletal muscle differentiation. Furthermore, p38 MAPK
inhibition abrogates myoblast fusion and differentiation (Segalés
et al., 2016). Based on this observation, we next investigated
whether p38 MAPK takes part in the S-phase peak and later
G0/G1 arrest promoted by SGE in C2C12 cells. To achieve this,
first C2C12 cells were cultured in growth medium (GM), and
then this medium was changed to differentiation medium (DM)
to induce differentiation. Cells were treated with synthetic
SGE (10 nM) in the presence or absence of p38 MAPK
inhibitor SB 203580 (10 µM) or vehicle alone for 12 h and
24 h. As illustrated in Fig. 1B, SGE-induced G0/G1 cell arrest
was abrogated when p38 MAPK was previously inhibited,
showing that SGE activates the p38 MAPK pathway to promote
the onset of muscle differentiation.
It has been reported that 1α,25(OH)2D3 stimulates the PI3K-Akt
pathway (Dwivedi et al., 2010) and other well-supported evidence has
suggested that AKT signaling has an important role in myoblast
differentiation (Gonzalez et al., 2004; Fujio et al., 2001; Vandromme
et al., 2001). It was reported that AKT overexpression enhances
myoblast differentiation, whereas AKT inhibition, by expression of a
dominant-negative AKT, blocks myotube formation. The suppression
of myogenesis caused by PI3-kinase inhibition is rescued by the
ectopic expression of a constitutively active AKT (Tureckova et al.,
2001). AKT participation in C2C12 differentiation by 1α,25(OH)2D3
was previously reported in C2C12 (Buitrago et al., 2012). However,
an experimental approach different from ours was used. In that report,
cells were grown in DM medium for 48 h before 1α,25(OH)2D3
(1 nM) treatment, and thus a different pattern ofAKTphosphorylation
was observed. In view of p38 MAPK and AKT implication in muscle
cells differentiation, we then studied whether SGE regulates p38
MAPK and AKT likewise regulates 1α,25(OH)2D3. To that end,
time course experiments were performed during SGE (10 nM) or
synthetic 1α,25(OH)2D3 (1 nM) treatment at the beginning of
C2C12 differentiation (1–48 h). Proteins from whole cell lysates
Fig. 2. SGE regulates AKT and p38 MAPK phosphorylation at the beginning of myogenesis. C2C12 cells were cultured in GM. To begin the
differentiation, this medium was withdrawn and then replaced by DM. Treatment was started by adding 10 nM of SGE or 1 nM of synthetic 1α,25(|OH)2D3
(1,25D) in DM during different periods of time (1–48 h). Western blots were performed with anti p-AKT, total AKT, p-p38 MAPK, and p38α and tubulin
antibodies. Tubulin was used as loading protein marker. Representative blots from three independent experiments (upper panel) and their quantification
(lower panel) are shown. Protein bands quantification was done using ImageJ. Results were then represented in bar graphs as phosphorylated protein
normalized with its corresponding total from treated conditions and referred to control (Fold) (lower panel). Significant differences between conditions at each
time point were analyzed by Student’s t-test, **P<0.01.
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were subjected to SDS-PAGE and p38-MAPK, and AKT protein
phosphorylation was analyzed by Western blot. The results
presented in Fig. 2 show that AKT phosphorylation increased
rapidly at 1 h and then decreased significantly after SGE or
1α,25(OH)2D3 treatment (24–48 h), whereas p38 MAPK
phosphorylation also increased at 1 h and remained elevated for
24 h to decrease later (48 h). Our study supports the hypothesis
that the effects of SGE in AKT phosphorylation are similar to
synthetic 1α,25(OH)2D3.
Myoblast fusion is essential for the development of skeletal muscle
myofibers. The formation of multinucleated muscle cells through
cell-fusion is a conserved mechanism from fruit flies to humans. Cell-
cell fusion of myoblasts give rise to the functional unit of muscle, the
multinucleated myofiber (Aguilar et al., 2013).
We have previously shown that SGE as synthetic 1α,25(OH)2D3
induces myoblasts fusion into myotubes (Gili el at., 2016). Results
from our laboratory have indicated that p38 MAPK activation
by 1α,25(OH)2D3 is VDR-dependent in C2C12 myoblasts under
a proliferative stage (Buitrago et al., 2013). It was also shown that
c-Src-dependent stimulation of MKK3 and 6 rapidly activates p38
MAPK, which in turn phosphorylates MAPK2 that subsequently
promotes the phosphorylation of heat-shock protein 27 in C2C12
Fig. 3. SB203580 and LY294002
inhibitors prevent myoblast
differentiation induced by SGE or
synthetic 1α,25(OH)2D3.
(A) Fluorescence photomicrographs
show C2C12 cells undergoing
differentiation for 72 h. Cells were treated
with vehicle (Ctrl, control), 1 nM of
1α,25(OH)2D3 (1,25D), or 10 nM of SGE,
or in presence of SB203580 (10 µM), or
LY294002 (10 µM), as described in the
text. (B) Fusion index was calculated and
represented in bar graphs from three
independent experiments. Significant
differences between conditions were
analyzed by one way ANOVA followed by
Bonferroni Test. Different letters indicate
statistical differences among groups for
each condition (P<0.05).
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myoblasts. In agreement with our findings, p38 MAPK involvement
in cell-cycle control of C2C12 cells stimulated with 1 nM of
1α,25(OH)2D3 has been previously demonstrated, providing key
information of a 1α,25(OH)2D3 mechanism in myogenesis regulation
(Buitrago et al., 2013). Thus, our study demonstrates SGE’s effect on
signaling pathways involved in myogenesis.
Four isoforms of p38 MAPK have been described; Wang and
collaborators have found that p38α, β and γ are required for C2C12
cell differentiation (Wang et al., 2008). SB203580 specifically inhibits
p38 isoforms α and β and has been successfully used to elucidate the
role of these isoforms. Results obtained using this inhibitor have
implicated p38α and β in skeletal muscle differentiation in vitro
(Kumar et al., 1997). p38 MAPK signal enables myoblasts to exit
the cell cycle at the beginning of differentiation (Lee et al., 2002).
Since p38α is a key signaling pathway involved in skeletal muscle
differentiation and inhibition of p38α activity abrogates myoblast
differentiation and fusion (Segalés et al., 2016), we assessed whether
p38MAPK, activated by SGE, takes part in the fusion of C2C12 cells
to form myotubes during differentiation. To that end, C2C12 cells
were induced to differentiate in DM and treated with SGE (10 nM) or
synthetic 1α,25(OH)2D3 (1 nM) in the presence or absence of
SB203580 (10 µM), or vehicle alone for 72 h. At the end of the
treatment, cells were fixed and incubated with anti-β-actin antibody
and DAPI, and then examined using a fluorescence microscope.
Images were collected and the fusion index was calculated as
described in the Materials and Methods. As illustrated by Fig. 3,
myotubes were developed in cells exposed to DM for 72 h (control)
and it was statistically and similarly increased by either SGE or
1α,25(OH)2D3. When cells were incubated with SB203580, cell
fusion was blocked. Moreover, when SB203580 was used in
combination with SGE (10 nM) or 1α,25(OH)2D3 (1 nM), the
ability of both compounds to induce myotube formation was
impaired (Fig. 3B). As reported by Irazoqui et al. (2014), our
studies confirm that p38α and β treated by 1α,25(OH)2D3 are
implicated in the withdrawal of myoblasts from the cell cycle to
promote differentiation. Furthermore, our results expand the
knowledge of the SGE mechanism that triggers myoblast fusion
through p38 MAPK.
Since AKT activation induced by synthetic 1α,25(OH)2D3 in
skeletal muscle differentiation was previously reported (Buitrago
et al., 2012), to study AKT participation in myotube fusion
promoted by SGE, the inhibitor LY294002 was used. LY294002
(10 µM) has been shown to effectively block PI3K activation
upstream of AKT in C2C12 cells by other authors (Gamell et al.,
2008). As indicated in Fig. 3A and B, inhibition of AKT activity
blocked myotube fusion induced by SGE as well as 1α,25(OH)2D3,
showing that AKT signaling is also part of SGE mechanism to
trigger C2C12 differentiation.
Until now, myogenic regulation is a theme of study. The precise
molecular mechanism is being explored and many novel genes and
factors are emerging as new candidates. In this regard, a number of
transcription factors and muscle-specific genes have been confirmed
as muscle determination factors (Brown et al., 2012; Wang et al.,
2012a, b). In this context, we next studied the pattern of myoD1,
myogenin and MCH2b gene expression during the differentiation
phase. C2C12were cultured for 24 h in GM, which was then replaced
with DM and SGE (10 nM), 1α,25(OH)2D3 (1 nM) or vehicle was
added for 24–72 h. mRNA gene expression was then analyzed by
qRT-PCR. As can be observed in Fig. 4A, myoD1 mRNA control
levels remained low throughout the period of analysis whereas in
treated conditions, myoD1 mRNA increased upon the addition of
SGE or 1α,25(OH)2D3. SGE-inducedmRNA synthesis was sustained
during the period of analysis in contrast to synthetic 1α,25(OH)2D3
that only increased significantly at 24 h (Fig. 4A). The early
differentiation marker myogenin also increased upon SGE or
1α,25(OH)2D3 treatment, however, myogenin mRNA induction by
1α,25(OH)2D3 started at 48 h in contrast to SGE (Fig. 4B). Finally,
the late differentiation marker, MHC2b, also increased significantly
by SGE or 1α,25(OH)2D3 at 72 h compared to control (Fig. 4C).
In conclusion, our results indicate that SGE regulates the cell
cycle and promotes myotube fusion through p38 MAPK and AKT
regulation in skeletal muscle C2C12 cells. Moreover, both vitamin




We obtained 1α,25(OH)2D3 from Cerbios AG, Lugano, Switzerland (http://
www.cerbios.ch) and an extract of dry leaves of the plant S. glaucophyllum,
containing 50 µg g−1 analytically determined 1α,25(OH)2D3, was kindly
provided by Herbonis AG (Augst, Switzerland). Dulbecco’s modified Eagle’s
medium (DMEM) low glucose, with l-glutamine and HEPES, without phenol
red, Immobilon P (PVDF) membranes, LY294002 and SB 203580 were from
Sigma-Aldrich. Sterile fetal bovine serum (FBS) and horse serum (HS) were
purchased from Natocor (Córdoba, Argentina). The antibodies used were:
anti-p-p38 MAPK (4511), p-AKT (9271), AKT (4685) from Cell Signaling
Technology; Goat anti-Rabbit, IgG-HRP (sc-2004) and anti-β-actin
(sc-47778) antibodies from Santa Cruz Biotechnology. DAPI, β-tubulin
antibody, Goat anti-Mouse IgG (H+L) Cross-Adsorbed Secondary Antibody,
Cyanine3 were from Thermo Fisher Scientific. PCR primers, Superscript
III reverse transcriptase (Invitrogen), Sybr green PCR master mix
Fig. 4. Genes regulation by SGE or synthetic 1α,25(OH)2D3 during onset of differentiation. C2C12 cells were treated with SGE (10 nM), 1α,25(OH)2D3
(1,25D, 1 nM), or vehicle alone (ctrl) in DM in time course experiments (24–72 h). Total RNA was extracted and reverse transcribed and data analysis was
performed for each gene expression by qRT-PCR. Bar graphs show quantitative results from three experiments performed in duplicate and expressed as a
ratio between mRNA of each gene (A) myoD1, (B) myogenin, (C) MHC2b in DM under control conditions (ctrl) or treated (1,25D or SGE) previously
normalized to GAPDH mRNA levels and to GM (time 0). The results were then represented in bar graphs. Significant differences between control and treated
(SGE or 1,25D) conditions at each time point were analyzed by Student’s t-test. ns: not significant. *P<0.05 and **P<0.01.
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(Applied Biosystems) were also from Thermo Fisher Scientific. High Pure
RNA Isolation Kit was from Roche (F. Hoffmann-La Roche Ltd., Madison,
USA).
Cell culture and treatment
We used the murine skeletal muscle cell line C2C12 to study myogenesis
(Gili et al., 2016). Cells were cultured with DMEM supplemented with 10%
heat-inactivated (30 min, 56°C) FBS, 1% nystatine, and 1% streptomycin,
GM at 37°C under a humidified atmosphere of 5% CO2 in air. C2C12
myoblasts cultured in these conditions resemble the activated satellite cells
(Yoshida et al., 1998). Myoblast differentiation was promoted as was
previously reported (Gili et al., 2016). Briefly, (with C2C12 cells at 70–80%
of confluence) GM was replaced with DMEM without phenol red,
supplemented with 2% HS (DM). C2C12 cells were incubated in DM
with 1α,25(OH)2D3 (1 nM) or SGE (10 nM) dissolved in less than 0.01%
ethanol as vehicle during the experimental period.
Cell lysates and protein content determination
C2C12 cells were scraped in 75 µl of lysis buffer and lysates were collected
by aspiration and centrifuged at 14,000 g for 15 min (Gili et al., 2016).
Proteins from supernatant were quantified using the Bradford procedure as
before (Gili et al., 2016; Bradford, 1976).
Western blot analysis
Proteins were separated on SDS-PAGE (10% gels) and electro transferred to
PVDF membranes. Membranes were then blocked and subjected to
immunoblotting (Gili et al., 2016). Incubation with primary antibodies,
(1:1000) in 0.1% TBST containing 2.5% dry milk, was performed overnight
at 4°C. After washing three times with 0.1% TBST, membranes were
incubated with secondary antibodies conjugated with peroxidase (1:5000)
in TBST buffer as primary antibodies, for 1 h at room temperature. Blot
signals were visualized using an enhanced chemiluminescence technique
(ECL) according to the manufacturer’s instructions (Amersham ECL
Western Blotting Detection Kit, GE Healthcare). Images were scanned and
quantified using ImageJ software.
Fluorescence microscopy
Cells were fixed with formaldehyde for 15 min. Fixed cells were then
incubated with anti-β-actin (1:50) overnight at 4°C and then with Goat anti-
Mouse IgG (H+L) Cross-Adsorbed Secondary Antibody, Cyanine3 for 1 h
and then with DAPI (1:1000) of a stock solution of 5 mg ml−1 for 30 min at
room temperature, in darkness. Samples were then washed three times
with phosphate-buffered saline (PBS), mounted and examined using
NIKON Eclipse Ti-S fluorescence microscope equipped with standard
filter sets (Gili et al., 2016). Images were collected using a digital camera.
Fusion index determination
Images collected from Fluorescence microscopy were merged with
Fiji software (ImageJ) and the fusion index was calculated as in our
previous work (Gili et al., 2016). Briefly, the fusion index (number of
nuclei in myotubes/total number of nuclei) was calculated by counting
nuclei in ten random fields from three culture dishes (five fields in
each dish).
Cell cycle analysis by flow cytometry
C2C12 cells were collected by trypsinization, washed with PBS twice and
then fixed in 70% of ethanol. Fixed cells were washed in PBS and re-
suspended with 500 µl of RNase-propidium iodide mix (BD Biosciences)
for 30 min. The fluorescence of DNAwas measured using a flow cytometer
(BD FACSCalibur) and the cell distribution in different phases of the
cellular cycle was analyzed by computer software (CELLQuest PRO,
Becton Dickinson, San Jose, USA).
RNA Isolation and quantitative RT-PCR
Total RNA for quantitative RT-PCR (qRT-PCR) analysis was isolated with
the High Pure RNA Isolation Kit (Roche) following the procedure provided
by manufacturer. Then 1 µg of RNA was reverse transcribed using the
Superscript III Reverse transcriptase and qRT-PCR reactions were performed
on the resulting cDNA in a 7500 Fast Real Time PCR system (Applied
Biosystems). Specific primers were used to detect myoD1, myogenin and
MHC2b mRNA levels. Gapdh mRNA was used to normalize gene
expression. Data of relative fold change was obtained by the comparative
CT method. Oligonucleotides used for amplification were: murine myoD1:
forward 5′-CAACGCCATCCGCTACATCG-3′ and reverse 5′-GTCCAGG-
TGCGTAGAAGGCA-3′; murine myogenin: forward 5′-TGCCGTGGGC-
ATGTAAGGT-3′ and reverse 5′-TGCGCAGGATCTCCACTTTAG-3′ and
murine MHC2b: forward 5′-CAATCAGGAACCTTCGGAACAC-3′ reverse
5′-CAATCAGGAACCTTCGGAACAC-3′ and murine Gapdh, forward
5′-GAAGGTGAAGGTCGGAGTC-3′ and reverse 5′-GAAGATGGTGAT-
GGGATTTC-3′.
Statistical analysis
Data are shown as mean±s.d. Cell cycle statistical analysis was performed
by one way ANOVA, followed by Tukey test. Index fusion was analyzed by
one way ANOVA, followed by Bonferroni test. Different superscript letters
indicate significant differences at P<0.05. Data from DNA quantification in
Fig. 1A, time-response studies obtained by qRT-PCR or Western blot were
analyzed by the two-tailed t-test. **P< 0.01 and *P< 0.05 were considered
statistically significant.
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